Workflow
Sino-Microelectronics(600360)
icon
Search documents
*ST华微(600360) - 吉林华微电子股份有限公司关于收到原控股股东归还全部占用资金及利息的公告
2025-08-15 09:15
证券代码:600360 证券简称:*ST 华微 公告编号:2025-063 吉林华微电子股份有限公司 关于收到原控股股东归还全部占用资金及利息的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司于 2025 年 2 月 12 日收到中国证监会吉林监管局下发的《关于对吉林华微 电子股份有限公司、上海鹏盛科技实业有限公司采取责令改正措施的决定》(吉证 监决〔2025〕4 号),要求公司在 6 个月内清收 149,067.82 万元被上海鹏盛及其关 联方非经营性占用的资金。 公司前期已收到上海鹏盛的《关于资金占用整改方案的承诺函》,上海鹏盛提 出 了 资 金 占 用 整 改 方 案 , 向 上 市 公 司 归 还 全 部 占 用 资 金 并 支 付 利 息 共 计 156,695.89 万元,其中:上海鹏盛将以分红款抵偿 1,105.93 万元,并以向亚东投 资转让所持公司全部股份所得资金清偿 155,589.96 万元。上述资金占用整改方案 已经公司第九届董事会第九次会议、第九届监事会第五次会议、2025 ...
康达新材: 成都中科华微电子有限公司审计报告
Zheng Quan Zhi Xing· 2025-08-14 16:39
Audit Opinion - The audit report states that the financial statements of Chengdu Zhongke Huami Microelectronics Co., Ltd. fairly reflect the company's financial position as of December 31, 2024, and March 31, 2025, in accordance with accounting standards [1][2]. Basis for Audit Opinion - The audit was conducted following the Chinese Certified Public Accountant Auditing Standards, ensuring independence and adherence to professional ethics [2][3]. Management and Governance Responsibilities - The management is responsible for preparing the financial statements in accordance with accounting standards and maintaining internal controls to prevent material misstatements due to fraud or error [2][3]. Auditor's Responsibilities - The auditor's goal is to obtain reasonable assurance that the financial statements are free from material misstatement, whether due to fraud or error, and to issue an audit report that includes the audit opinion [3][4]. Financial Position - As of March 31, 2025, the total assets of the company amounted to CNY 291,835,115.98, compared to CNY 273,351,433.20 as of December 31, 2024 [6][7]. - The total liabilities and equity also matched the total assets at CNY 291,835,115.98 as of March 31, 2025 [7]. Income Statement - For the first quarter of 2025, the total operating income was CNY 48,022,888.82, while for the entire year of 2024, it was CNY 100,528,105.71 [6][8]. - The net profit for the first quarter of 2025 was CNY 20,126,922.77, compared to CNY 32,905,827.02 for the full year of 2024 [8]. Cash Flow Statement - The net cash flow from operating activities for the first quarter of 2025 was negative at CNY -13,175,072.81, while for the full year of 2024, it was CNY -14,740,200.20 [8]. - The net cash flow from investing activities was also negative at CNY -16,259,345.86 for the first quarter of 2025 [8]. Changes in Equity - The total equity attributable to the parent company as of March 31, 2025, was CNY 110,730,206.56, an increase from CNY 105,955,783.79 as of December 31, 2024 [7].
康达新材:拟收购成都中科华微电子有限公司51%股权
Mei Ri Jing Ji Xin Wen· 2025-08-14 11:38
康达新材(SZ 002669,收盘价:13.8元)8月14日晚间发布公告称,公司拟以现金方式使用自有及自筹 资金人民币约2.75亿元收购成都中科华微电子有限公司(简称"中科华微")51%的股权。交易完成后, 中科华微将成为公司的控股子公司,并纳入公司合并报表范围。 (文章来源:每日经济新闻) 2024年1至12月份,康达新材的营业收入构成为:胶粘剂行业占比72.62%,电子产品业务占比8.48%, 合成树脂占比6.1%,其他业务占比4.28%,医药中间体占比3.31%。 ...
吉林国资旗下亚东投资拟入主*ST华微
Zheng Quan Shi Bao· 2025-08-13 05:51
Core Viewpoint - *ST Huamei (600360) is undergoing a significant change in its shareholding structure, with Shanghai Pengsheng Technology Industrial Co., Ltd. transferring 214 million shares (22.32% of total shares) to Jilin Yadong State Capital Investment Co., Ltd. to address financial issues and promote the development of the semiconductor industry in Jilin Province [1][2] Group 1 - The share transfer agreement aims to use the proceeds to repay a total of 1.556 billion yuan owed by Shanghai Pengsheng and its affiliates to *ST Huamei [1] - After the transaction, Shanghai Pengsheng will no longer hold shares in *ST Huamei, and the controlling shareholder will change to Jilin Yadong Investment, with the actual controller being the Jilin Provincial State-owned Assets Supervision and Administration Commission [1] - The stock of *ST Huamei will resume trading on June 26 [1] Group 2 - Previously, *ST Huamei received a directive from the Jilin Securities Regulatory Bureau to recover 1.491 billion yuan of non-operating funds occupied by Shanghai Pengsheng and its affiliates within six months [2] - Shanghai Pengsheng has pledged all its shares in *ST Huamei to Jilin Maijike Semiconductor Co., Ltd. as collateral for repaying the occupied funds [2] - The total amount to be repaid by Shanghai Pengsheng, including interest, is 1.567 billion yuan, with part of it to be settled through dividend payments [2]
*ST华微未按期完成资金清收开始停牌,亚东投资:正抓紧推进转让
Di Yi Cai Jing· 2025-08-13 03:52
这表明此前吉林省国资委旗下平台公司通过受让控股股东股权、归还后者占用上市公司款项,以避免 *ST华微退市的计划进展未达预期。 第一财经记者独家采访到吉林省国资委旗下平台公司——吉林省亚东国有资本投资有限公司(下称:亚 东投资)相关负责人,相关负责人回应记者称:各方正在抓紧推进协议转让事项,详细情况请关注上市 公司公告。 *ST 华微8月13日起停牌,预计不超2个月。 *ST华微(600360.SH)8月12日晚间发布公告称,因未能在规定期限内完成资金占用清收,股票于8月 13日开市起停牌,预计停牌时间不超过2个月。 今年2月12日,*ST华微收到中国证监会吉林监管局下发的《关于对吉林华微电子股份有限公司、上海 鹏盛科技实业有限公司采取责令改正措施的决定》,要求公司在6个月内清收14.91亿元被上海鹏盛及其 关联方非经营性占用的资金。然而截至8月12日,公司未能完成这一清收任务。 今年6月26日,*ST华微发布《关于控股股东签署〈股份转让协议〉暨控制权拟发生变更的提示性公 告》、以及《关于控股股东资金占用整改方案的公告》,公告称,*ST华微控股股东上海鹏盛科技实业 有限公司,计划向亚东投资转让其持有的2.14亿 ...
吉林华微电子股份有限公司 关于无法在责令改正期限内完成资金占用整改暨股票停牌的公告
Core Viewpoint - The company, Jilin Huamei Electronics Co., Ltd., is facing a potential stock suspension due to failure to rectify the misuse of funds by the deadline set by the regulatory authority, which is August 12, 2025 [2][5]. Group 1: Company Actions and Progress - As of the announcement date, the company has not completed the required rectification before the deadline [3]. - The controlling shareholder, Shanghai Pengsheng, has committed to resolving the non-operational fund occupation issue through various means, including cash repayment and asset disposal [3]. - The company has implemented measures such as offsetting the controlling shareholder's cash dividends of 11.0593 million yuan against the occupied funds [3]. - Shanghai Pengsheng has proposed a rectification plan to return all occupied funds totaling 156.9589 million yuan, which includes 11.0593 million yuan from dividends and 155.58996 million yuan from the sale of shares [3][4]. Group 2: Impact of Non-Compliance - If the company fails to recover the occupied funds by the deadline, its stock will be suspended from trading starting August 13, 2025, and may face delisting if rectification is not completed within the subsequent two months [5][6]. - The company is currently operating normally despite the ongoing issues [7]. Group 3: Conditions for Resumption of Trading - The company’s stock will resume trading if the rectification is completed within the suspension period [6]. - If the rectification is not completed during the suspension, the stock will be subject to delisting risk warnings [6].
*ST华微: 吉林华微电子股份有限公司关于无法在责令改正期限内完成资金占用整改暨股票停牌的公告
Zheng Quan Zhi Xing· 2025-08-12 16:14
证券代码:600360 证券简称:*ST 华微 公告编号:2025-061 吉林华微电子股份有限公司 关于无法在责令改正期限内完成资金占用整改 暨股票停牌的公告 ? 证券停复牌情况:适用 因吉林华微电子股份有限公司(以下简称"公司")在责令改正规定期限(2025 年 8 月 12 日)届满前未完成改正,公司股票将自 2025 年 8 月 13 日开市起停牌, 预计停牌时间不超过 2 个月。本公司的相关证券停复牌情况如下: 停牌 证券代码 证券简称 停复牌类型 停牌起始日 停牌终止日 复牌日 期间 公司于 2025 年 2 月 12 日收到中国证监会吉林监管局下发的《关于对吉林华 微电子股份有限公司、上海鹏盛科技实业有限公司采取责令改正措施的决定》 (吉 证监决〔2025〕4 号),要求公司在 6 个月内清收 149,067.82 万元被占用资金。具 体内容详见公司于 2025 年 2 月 13 日披露的《吉林华微电子股份有限公司关于收 到中国证券监督管理委员会吉林监管局 <行政监管措施决定书> 暨可能被实施退市 风险警示的风险提示性公告》(公告编号:2025-014)。为完成整改,公司须清收 全部被控股股东及 ...
金橙子拟收购萨米特55%股权;瑞康医药副总裁李喆解除留置;*ST华微无法在责令改正期限内完成整改|公告精选
Mei Ri Jing Ji Xin Wen· 2025-08-12 14:55
Mergers and Acquisitions - Jin Chengzi plans to issue shares and pay cash to acquire 55% stake in Samit from eight parties including Wang Yongyang and Huang Meng, while also raising supporting funds [1] - Quzhou Development intends to purchase 95.46% of Xian Dao Electronic Technology Co., Ltd. through share issuance and will raise supporting funds [2] Performance Disclosure - Zhuyue Group reported a net profit of 585 million yuan for the first half of 2025, representing a year-on-year increase of 57.83%, with total revenue of 10.412 billion yuan, up 14.89% [3] - Zhenlei Technology announced a net profit of 62.32 million yuan for the first half of 2025, marking a significant year-on-year growth of 1006.99%, with revenue of 205 million yuan, up 73.64% [4] Shareholding Changes - Baichuan Co., Ltd. major shareholder Zheng Tiejiang plans to reduce his stake by up to 3%, equivalent to 17.83 million shares, from September 4 to December 3, 2025, due to personal financial needs [5] - Taiping Bird's shareholder Chen Hongchao intends to reduce his stake by no more than 3%, or 14.13 million shares, from August 19 to November 18, 2025, also for personal financial reasons [6] - Kanghua Biology's shareholder Chuanfa Selected No. 3 plans to reduce his stake by up to 3%, or 389,840 shares, within three months from the disclosure date [7] Risk Matters - *ST Huamei announced it failed to rectify fund occupation issues within the mandated period, leading to a suspension of its stock starting August 13, 2025, with potential delisting risks if not resolved within two months [8] - Ruikang Pharmaceutical reported that its director and board secretary Li Zhe had his detention lifted and changed to a warning measure, with normal business operations continuing [9]
无法在责令改正期限内完成资金占用整改,*ST华微8月13日起停牌
Bei Jing Shang Bao· 2025-08-12 13:16
Core Viewpoint - *ST Huamei (600360) announced that it could not complete the rectification of fund occupation within the mandated deadline, leading to a suspension of its stock from August 13, with an expected duration of no more than two months [1][2]. Group 1: Company Announcement - On February 12, 2025, *ST Huamei received a directive from the Jilin Securities Regulatory Bureau, requiring the company to recover 1.491 billion yuan of occupied funds within six months [1]. - The company has not completed the rectification by the deadline of August 12, as stated in the announcement [2]. - The controlling shareholder has expressed willingness to cooperate in resolving the non-operational fund occupation issue through various means, including cash repayment and asset disposal [2]. Group 2: Rectification Plan - The controlling shareholder, Shanghai Pengsheng, has committed to returning all occupied funds and paying interest totaling 1.567 billion yuan, with 11.0593 million yuan to be offset against cash dividends [2]. - Shanghai Pengsheng plans to clear 1.556 billion yuan by transferring all shares held in *ST Huamei to Yadong Investment [2]. - The company and related parties will expedite the transfer agreement to recover the occupied funds as soon as possible [2]. Group 3: Stock Market Reaction - On August 12, *ST Huamei's stock reached the daily limit, closing at 9 yuan per share, with a total market capitalization of 8.643 billion yuan [3].
金橙子拟收购萨米特55%股权;*ST华微无法在责令改正期限内完成整改|公告精选
Mei Ri Jing Ji Xin Wen· 2025-08-12 12:44
Mergers and Acquisitions - Jin Chengzi plans to issue shares and pay cash to acquire 55% stake in Samit from eight parties including Wang Yongyang and Huang Meng, while also raising matching funds [1] - Quzhou Development intends to purchase 95.46% of Xian Dao Electronic Technology Co., Ltd. through share issuance and will raise matching funds [2] Earnings Disclosure - Zhuyue Group reported a net profit of 585 million yuan for the first half of 2025, representing a year-on-year increase of 57.83%, with total revenue of 10.412 billion yuan, up 14.89% [3] - Zhenlei Technology announced a net profit of 62.32 million yuan for the first half of 2025, a staggering year-on-year growth of 1006.99%, with revenue of 205 million yuan, increasing by 73.64% [4] Shareholding Changes - Baichuan Co., Ltd. major shareholder Zheng Tiejiang plans to reduce his stake by up to 3%, amounting to no more than 17.83 million shares, due to personal financial needs, from September 4 to December 3, 2025 [5] - Taiping Bird's shareholder Chen Hongchao intends to reduce his stake by no more than 3%, equivalent to 14.13 million shares, for personal financial reasons, from August 19 to November 18, 2025 [6] - Kanghua Biology's shareholder Chuanfa Selected No. 3 plans to reduce his stake by up to 3%, or 389,840 shares, within three months from the 15th trading day after the announcement [7] Risk Matters - *ST Huamei announced that it failed to rectify fund occupation issues within the mandated period, leading to a suspension of its stock starting August 13, 2025, with potential delisting risks if not resolved within two months [8] - Ruikang Pharmaceutical reported that its director and board secretary Li Zhe has had his detention lifted and is now under a directive to be monitored, with normal business operations continuing [9]